Related Experiment Video
Updated: Aug 11, 2026

13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 3, 2013
[Decision making analysis in the treatment of prostate cancer]
Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 29, 1998
Abstract:
The decision analysis technique has been used to estimate the benefits of treatment strategies for a variety of diseases. This analysis demonstrated that a selective treatment with a reasonable specificity and sensitivity for detecting clinically significant cancer is more beneficial to the patients with T1c cancer under 70 years of age than radical prostatectomy or watchful waiting assigned to all patients. Moreover, it was clearly indicated that quality-of-life (QOL) is the most important factor for deciding the optimal treatments of prostate cancer.

